Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding status notice from the page; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe updated page shows minor visual/layout adjustments with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference5%

- Check69 days agoChange DetectedAdded a new page revision tag (v3.1.0) and removed several MedlinePlus topics, simplifying the topic scope. No core content or time-sensitive information appears updated.SummaryDifference0.8%

- Check84 days agoChange DetectedRevision updated to v3.0.2 (replacing v3.0.1); the Back to Top element was removed. No other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.